The coffee diterpenes cafestol and kahweol raise serum cholesterol in humans. Each 10 mg of cafestol consumed per day elevates cholesterol by 5 mg/dL (0.13 mmol/L). Diterpene levels in various coffee brews were examined. Scandinavian boiled coffee contained (mean f SD) 3.0 f 2.8 mg, French press coffee 3.5 f 1.2 mg, and TurkisWGreek coffee 3.9 f 3.2 mg of cafestol per cup. Consumption of five cups per day of any of these coffee types could thus elevate serum cholesterol by 8-10 mgl dL. Italian espresso coffee contained 1.5 f 1.0 mg of cafestol per cup, five cups theoretically raising cholesterol by 4 mg/dL. Brewing time had little effect of diterpenes. Brewing strength increased diterpenes in boiled, French press, and espresso coffee but not in TurkisWGreek coffee. Diterpenes in instant, drip filtered, and percolated brews were negligible. Regular and decaffeinated coffees had similar diterpene contents. High chronic intake of French press coffee or TurkisldGreek coffee could increase serum cholesterol and thus coronary risk similar to that reported previously for Scandinavian boiled coffee.
The coffee diterpene cafestol occurs in both robusta and arabica beans. It is present in unfiltered coffee brews and raises serum concentrations of cholesterol, triacylglycerols, and alanine aminotransferase in humans. The effects are linear with the cafestol dose. Unfiltered coffee also contains the related compound kahweol, which occurs only in the major coffee strain arabica. The activity of kahweol is unknown. In a randomized, double-blind crossover study, we gave 10 healthy male volunteers either pure cafestol (61-64 mg/d) or a mixture of cafestol (60 mg/d) and kahweol (48-54 mg/d) for 28 d. Relative to baseline values, cafestol raised mean (+/-SEM) total serum cholesterol concentrations by 0.79 +/- 0.14 mmol/L (31 +/- 5 mg/dL), low-density-lipoprotein (LDL) cholesterol by 0.57 +/- 0.13 mmol/L (22 +/- 5 mg/dL), fasting triacy-glycerols by 0.65 +/- 0.12 mmol/L (58 +/- 11 mg/dL), and alanine aminotransferase by 18 +/- 2 U/L (all P < 0.01). Relative to cafestol alone, the mixture of cafestol plus kahweol increased total cholesterol by another 0.23 +/- 0.16 mmol/L (9 +/- 6 mg/dL) (P = 0.08), LDL cholesterol by 0.23 +/- 0.16 mmol/L (9 +/- 6 mg/dL) (P = 0.09), triacylglycerols by 0.09 +/- 0.10 mmol/L (8 +/- 9 mg/dL) (P = 0.20), and alanine aminotransferase by 35 +/- 11 U/L (P = 0.004). Thus, the effect of cafestol on serum lipid concentrations was much larger than the additional effect of kahweol, and the hyperlipidemic potential of unfiltered coffee mainly depends on its cafestol content. Both cafestol and kahweol raised alanine aminotransferase concentrations, and their hyperlipidemic effect thus seems not to be coupled with their effect on liver cells.
Coffee beans of commercially important Coffea species contain the diterpene cafestol, which raises serum cholesterol in humans. Coffee diterpenes also have shown anticarcinogenic properties in experimental animals. We determined levels of cafestol and other diterpenes in nine wild African Coffea species, in a search for a species without the cholesterol-raising cafestol. In addition, data on diterpene profiles might assist in the taxonomic grouping of Coffea species. Each Coffea species we investigated contained cafestol. Kahweol concentrations may be related to the geographical distribution of the Coffea species. 16-O-Methylcafestol was only present in Coffea canephora, Coffea stenophylla, and Coffea liberica var. dewevrei. A new diterpene was found in C. stenophylla and tentatively identified as 16-O-methylkahweol. Another four new diterpenes, which seem to contain an additional double bond compared to kahweol, were found in Coffea salvatrix and Coffea pseudozanguebariae, suggesting that these two species are closely related. In conclusion, cafestol is universally present in Coffea species. Amounts of kahweol, 16-O-methylcafestol, 16-O-methylkahweol, and the four newly found diterpenes present in various coffee beans may prove useful in the taxonomic classification of Coffea species.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.